MA51514A - Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes - Google Patents

Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes

Info

Publication number
MA51514A
MA51514A MA051514A MA51514A MA51514A MA 51514 A MA51514 A MA 51514A MA 051514 A MA051514 A MA 051514A MA 51514 A MA51514 A MA 51514A MA 51514 A MA51514 A MA 51514A
Authority
MA
Morocco
Prior art keywords
liposomes
injectable compositions
antifungal products
products encapsulated
triterpenoid
Prior art date
Application number
MA051514A
Other languages
English (en)
Inventor
Rajeshwar Motheram
Original Assignee
Scynexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scynexis Inc filed Critical Scynexis Inc
Publication of MA51514A publication Critical patent/MA51514A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
MA051514A 2018-01-02 2018-12-21 Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes MA51514A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862612893P 2018-01-02 2018-01-02

Publications (1)

Publication Number Publication Date
MA51514A true MA51514A (fr) 2021-04-07

Family

ID=65024141

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051514A MA51514A (fr) 2018-01-02 2018-12-21 Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes

Country Status (27)

Country Link
US (2) US20200338002A1 (fr)
EP (2) EP3735226B1 (fr)
JP (2) JP7378401B2 (fr)
KR (1) KR20200105875A (fr)
CN (2) CN111655237B (fr)
AU (1) AU2018399599B2 (fr)
BR (1) BR112020013448A2 (fr)
CA (1) CA3087176A1 (fr)
DK (1) DK3735226T3 (fr)
EA (1) EA202091626A1 (fr)
ES (1) ES2927051T3 (fr)
HR (1) HRP20221295T1 (fr)
HU (1) HUE060400T2 (fr)
IL (1) IL275758A (fr)
LT (1) LT3735226T (fr)
MA (1) MA51514A (fr)
MD (1) MD3735226T2 (fr)
MX (1) MX2020006992A (fr)
PL (1) PL3735226T3 (fr)
PT (1) PT3735226T (fr)
RS (1) RS63687B1 (fr)
SA (1) SA520412362B1 (fr)
SG (1) SG11202006313WA (fr)
SI (1) SI3735226T1 (fr)
TW (1) TW201929853A (fr)
UA (1) UA126096C2 (fr)
WO (1) WO2019135954A1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP1706148A2 (fr) * 2004-01-14 2006-10-04 Gilead Sciences, Inc. Dispersions a base de lipides utiles dans l'administration de medicaments
JP5245057B2 (ja) 2006-04-03 2013-07-24 メルク・シャープ・アンド・ドーム・コーポレーション 抗真菌剤
WO2009045311A1 (fr) * 2007-09-28 2009-04-09 Merck & Co., Inc. Agents antifongiques
EP2293787A1 (fr) * 2008-04-25 2011-03-16 Nanobio Corporation Nanoemulsions destinées à traiter des infections fongiques, et des infections provoquées par de la levure et de la moisissure
US8188085B2 (en) 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
PL3247711T3 (pl) * 2015-01-19 2022-06-27 Scynexis, Inc. Nowoczesne sole i polimorfy scy-078

Also Published As

Publication number Publication date
WO2019135954A1 (fr) 2019-07-11
PL3735226T3 (pl) 2022-12-19
SI3735226T1 (sl) 2022-11-30
MD3735226T2 (ro) 2023-03-31
RS63687B1 (sr) 2022-11-30
HRP20221295T1 (hr) 2022-12-23
EP3735226A1 (fr) 2020-11-11
PT3735226T (pt) 2022-09-20
EA202091626A1 (ru) 2020-09-22
JP2021508728A (ja) 2021-03-11
HUE060400T2 (hu) 2023-02-28
AU2018399599A1 (en) 2020-07-16
CN111655237B (zh) 2023-02-03
BR112020013448A2 (pt) 2020-12-01
DK3735226T3 (da) 2022-10-24
KR20200105875A (ko) 2020-09-09
US20200338002A1 (en) 2020-10-29
CA3087176A1 (fr) 2019-07-11
IL275758A (en) 2020-08-31
UA126096C2 (uk) 2022-08-10
ES2927051T3 (es) 2022-11-02
LT3735226T (lt) 2022-11-10
AU2018399599B2 (en) 2022-09-01
EP3735226B1 (fr) 2022-08-10
MX2020006992A (es) 2020-09-09
SG11202006313WA (en) 2020-07-29
CN111655237A (zh) 2020-09-11
EP4137123A1 (fr) 2023-02-22
SA520412362B1 (ar) 2022-12-15
JP2024012452A (ja) 2024-01-30
TW201929853A (zh) 2019-08-01
CN115998684A (zh) 2023-04-25
JP7378401B2 (ja) 2023-11-13
US20230277455A1 (en) 2023-09-07

Similar Documents

Publication Publication Date Title
MA46696A (fr) Formulations injectables à dose unique prêtes à l'emploi
DK3826477T3 (da) Poseprodukt med flydende smagssammensætning
CY1121155T1 (el) Ενωσεις ν-ετεροαρυλιου υποκατεστημενες με ν-αζασπιροκυκλοαλκανιο και συνθεσεις για την αναστολη της δραστηριοτητας της shp2
ZA201707975B (en) Improvements in or relating to encapsulated perfume compositions
MA50662A (fr) Mélanges synergiques pour la lutte contre des champignons dans des céréales
ITUB20160050A1 (it) Agitatore di una macchina per la produzione e l'erogazione di prodotti di gelateria.
MA42629A (fr) Produit à base de protéine de moule à action adhésive et son application pour inhiber les muqueuses
IT201700087359A1 (it) Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
MA49116A (fr) Compositions pharmaceutiques contenant de l'insuline
MX369571B (es) Composicion para prevenir o tratar enfermedades del higado graso.
IL262195A (en) Methods and preparations for improving the anti-inflammatory effects of interleukin 10
FR3040260B1 (fr) Composition repulsive contre les insectes vecteurs de maladies tropicales sous forme de spray
IL287628A (en) Injectable pharmaceutical compounds and their uses
AR095138A1 (es) Composición y uso de la misma
MA51514A (fr) Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes
FR3020758B1 (fr) Composition pour ameliorer l'hygiene buco-dentaire
ZA201707938B (en) Improvements in or relating to encapsulated perfume compositions
IT201700087376A1 (it) Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
FR3006587B1 (fr) Composition pour corriger les dyschromies cutanees et ameliorer l'homogeneite du teint
AR104184A1 (es) Composición pesticida que comprende metomilo y lufenuron
GB201809253D0 (en) Improvements in or relating to organic material
UA116755C2 (uk) Фармацевтична композиція у формі супозиторіїв з ранозагоюючою, антиерозійною, протизапальною, антимікробною, протигрибковою, імуномодулюючою та антиоксидантною дією
GB201800467D0 (en) Improvements in or relating to organic material
MA55205A (fr) Formulations injectables prêtes à l'emploi
IT201600074068A1 (it) Composizione per l'incorporazione di sostanze attive in un prodotto tessile e metodo per realizzare tale incorporazione.